Skip to search formSkip to main contentSkip to account menu

P-VABEC

Known as: BLEO/CTX/DOX/PRED/VCR/VP-16, Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine, VACOP-B 
A chemotherapy combination consisting of bleomycin, cyclophosphamide, doxorubicin, etoposide, prednisone and vincristine.
National Institutes of Health

Related topics

Related topics

9 relations
BleomycinCyclophosphamideDoxorubicinDoxorubicin Hydrochloride

Broader (2)

VACOP-B protocolcisplatin/cyclophosphamide/etoposide protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • A. Ng
  • 2017
  • Corpus ID: 78770524
Primary mediastinal (thymic) large B-cell lymphoma (PMBL) is a distinct entity that arises from the thymic B cell, with clinical… 
Review
2014
Review
2014
The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients
The purpose of this study is to investigate the most suitable first-line approach and the best combination treatment for primary… 
2002
2002
Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis
The aim of our study was to evaluate the impact of an early intensification programme including chemotherapy (CHT), autologous… 
2000
2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's…
BACKGROUND AND OBJECTIVE Sequential treatment with the addition of high-dose therapy (HDT) and peripheral blood progenitor cell… 
Review
1998
Review
1998
The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.
1998
1998
High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen.
Seven patients, all females out of 29 with non-Hodgkin's lymphoma (NHL) (16 males and 13 females) treated with the VACOP-B… 
1997
1997
Case history. 2: The use of epoetin alfa before high-dose chemotherapy.
A 31-year-old male Jehovah's Witness was diagnosed with non-Hodgkin's lymphoma (intermediate grade, stage 1KB). After treatment… 
1996
1996
62 P - CIP regimen as consolidation therapy after P-VABEC in aggressive NHL of the elderly
1994
1994
Alternating chemotherapy regimen (P‐VABEC) for intermediate and high‐grade non‐Hodgkin's lymphoma of the middle aged and elderly
An intensive third generation regimen (P‐VABEC) including adriamycin, etoposide, cyclophosphamide, vincristine, bleomycin and… 
1993
1993
Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas of the elderly.
Between July 1990 and March 1992, 23 elderly patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)